Methylprednisolone administration in primary biliary cirrhosis increases cholic acid turnover, synthesis, and deoxycholate concentration in bile

Digestive Diseases and Sciences

Volumn 44, Issue 12, 1999, Pages 2478-2483

  Mazzella, Giuseppe ^a,b,c   Fusaroli, Pietro ^a,b   Pezzoli, Alessandro ^a,b   Azzaroli, Francesco ^a,b   Mazzeo, Costanza ^a,b   Zambonin, Laura ^a,b   Simoni, Patrizia ^a,b   Festi, Davide ^a,b   Roda, Enrico ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Bile acids; Cholic acid; Corticosteroids; Deoxycholic acid; Primary biliary cirrhosis

Indexed keywords

CHOLIC ACID; DEOXYCHOLIC ACID; METHYLPREDNISOLONE;

ADULT; AGED; ARTICLE; BILE ACID METABOLISM; BILE ACID SYNTHESIS; CHOLESTEROL BILE LEVEL; CLINICAL ARTICLE; DRUG SAFETY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIPID METABOLISM; LIVER TOXICITY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL;

EID: 0033402588     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026687022202     Document Type: Article

References (44)

1. 1. Kaplan MM: Primary biliary cirrhosis. N Engl J Med 316:521-528, 1987
2. 2. James SP, Hoofnagle JH, Strober W, Jones EA: Primary biliary cirrhosis: A model autoimmune disease. Ann Intern Mod 99:500-512, 1983
3. 3. James SP, Elson CO, Jones EA, Strobert W: Abnormal regulation of immunoglobulin synthesis in vitro in primary biliary cirrhosis. Gastroenterology 79:242-254, 1980
4. 4. Bjorkland A, Totterman TH: Is primary biliary cirrhosis an autoimmune disease? Scand J Gastroenterol 29(suppl 204):32-39, 1994
5. 5. Hofmann AF, Popper H: Ursodeoxycholic acid for primary biliary cirrhosis. Lancet 2:398-399, 1987
6. 6. Matloff DS, Alpert E, Resnick RH, Kaplan MM: A prospective trial of D-penicillamine in primary biliary cirrhosis. N Engl J Med 306:319-326, 1982
7. 7. Christensen E, Neuberger J, Crowe J, Altman DG, Popper H, Portmann B, Doniach D, Ranek L, Tygstrup N, Williams R: Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Gastroenterology 89:1084-1091, 1985
8. 8. Kaplan MM, Alling DW, Zimmerman HJ, Wolfe HJ, Sepersky RA, Hirsch GS, Elta GH, Glick KA, Eagen KA: A prospective trial of colchicine for primary biliary cirrhosis. N Engl J Med 315:1448-1454, 1986
9. 9. Lombard M, Portmann B, Neuberger J, Williams R, Tygstrup N, Ranek L, Ring-Larsen H, Rodes J, Navasa M, Trepo C, Pape G, Schou G, Badsberg JH, Andersen PK: Cyclosporin A treatment in primary biliary cirrhosis: Results of a long term placebo controlled trial. Gastroenterology 104:519-526, 1993
10. 10. Wiesner RH, Grambsch PM, Lindor KD, Ludwig J, Dickson ER: Clinical and statistical analyses of now and evolving therapies for primary biliary cirrhosis. Hepatology 8:668-676, 1988
11. 11. Poupon RE, Lindor KD, Cauc-Dudek K, Dickson ER, Poupon R, Heathcote EJ: Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 113:884-890, 1997
12. 12. Beukers R, Schalm SW: Immunosuppressive therapy for primary biliary cirrhosis. J Hepatol 14:1-6, 1992
13. 13. Mitchison HC, Palmer JM, Bassendine MF, Watson AJ, Record CO, James OFW: A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results. J Hepatol 15:336-344, 1992
14. 14. Duncan Phillips J, Stelzner M, Zeng H, Kelly RE, Fonkalsrud EW: Alterations in gastrointestinal motility during postoperative acute corticosteroid withdrawal. Am J Surg 162:251-255, 1991
15. 15. Wolfhagen FH, van Buuren HR, Schalm SW: Combined treatment with ursodeoxycholic acid and prednisone in primary biliary cirrhosis. Neth J Med 44:84-90, 1994
16. 16. Leuschner M, Guldutuna S, You T, Hubner K, Bhatti S, Leuschner U: Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis. J Hepatol 25:49-57, 1996
17. 17. Grundy SM, Metzger AL: A physiological method for estimation of hepatic secretion of biliary lipids in man. Gastroenterology 62:1200-1217, 1972
18. 18. Mazzella G, Parini P, Festi D, Bazzoli F, Aldini R, Roda A, Tonelli D, Cipolla A, Salzetta A, Roda E: Effect of simvastatin, ursodeoxycholic acid, and simvastatin and ursodeoxycholic acid on biliary lipid secretion and cholic acid kinetics in non-familial hypercholesterolemia. Hepatology 15:1072-1078, 1992
19. 19. Mazzella G, Bazzoli F, Villanova N, Simoni P, Festi D, Roda A, Aldini R, Roda E: Effect of gemfibrozil administration on biliary lipid secretion in hyperlipidemic patients: A crossover study with clofibrate. Scand J Gastroenterol 25:1227-1234, 1990
20. 20. Roda A, Festi D, Sama C, Mazzella G, Aldini R, Roda E, Barbara L: Enzymatic determination of cholesterol in bile. Clin Chim Acta 64:377-381, 1975
21. 21. Talalay P: Enzymatic analysis of steroid hormones. Methods Biochem Ann 8:119-143, 1960
22. 22. Svamborg A, Svennerholm M: Plasma total lipid cholesterol, tryglicerides, phospholipids and free fatty acids in healthy Scandinavian population. Acta Med Scand 169:43-49, 1961
23. 23. Abell LL, Levy BB, Bride BB. Cholesterol in serum. In Standard Methods of Clinical Chemistry, Vol 2. D Saligson (ed). New York, Academic Press, 1958, pp 26-33
24. 24. Hyden S: A turbidimetric method for determination of higher polyethylenglycols in biological materials. Ann R Agric Coll Swed 22:139-149, 1955
25. 25. Roda A, Cerré C, Simoni P, Polimeni C, Vaccari C, Pistillo A: Determination of free and amidated bile acids by HPLC with evaporative light-scattering mass detection. J Lipid Res 33:1393-1402, 1992
26. 26. Carey MC, Small DM: The physical chemistry of cholesterol solubility in bile: Relationship to gallstone formation and dissolution in man. J Clin Invest 61:998-1026, 1978
27. 27. Carey MC: Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res 19:945-955, 1978
28. 28. Lindstedt S: The turnover of cholic acid in man. Acta Physiol Scand 40:1-9, 1957
29. 13C-labeled bile acids. J Lipid Res 25:1313-1319, 1984
30. 30. Glantz SA: Primer of Biostatistics. New York, McGraw-Hill, 1987
31. 31. Lim AG, Jazrawi RP, Northfield TC: The ursodeoxycholic acid story in primary biliary cirrhosis. Gut 37:301-304, 1995
32. 32. Princen HMG, Meijer P, Hofstee B: Dexamethasone regulated bile acid synthesis in monolayer cultures of rat hepatocytes by induction of cholesterol 7α-hydroxylasc. Biochem J 262:341-348, 1989
33. 33. Vlahcevic ZR, Pandack WM, Heuman DM, Hylemon PB: Function and regulation of hydroxylases involved in the bile acid biosynthesis pathways. Semin Liver Dis 12:403-419, 1992
34. 34. Carulli N, Loria P, Bertolotti M, Ponz de Leon M, Menozzi D, Medici G, Piccagli I: Effects of acute changes of bile acid pool composition on biliary lipid secretion. J Clin Invest 74:614-624, 1984
35. 35. Roda E, Mazzella G, Bazzoli F, Villanova N, Minutello A, Simoni P, Ronchi M, Poggi C, Festi D, Aldini R, Roda A: Effect of ursodeoxycholic acid administration on biliary lipid secretion in primary biliary cirrhosis. Dig Dis Sci 34: 52S-58S, 1989
36. 36. Mazzella G, Parini P, Bazzoli F, Villanova N, Festi D, Aldini R, Roda A, Cipolla A, Polimeni C, Tonelli D, Roda E: Ursodeoxycholic acid administration on bile acid metabolism in patients with early stages of primary biliary cirrhosis. Dig Dis Sci 38:896-902, 1993
37. 37. Roda E, Aldini R, Mazzella G, Roda A, Sama C, Festi D, Barbara L: Enterohepatic circulation of bile acids after cholecystectomy. Gut 19:640-649, 1978
38. 38. Guldutuna S, Leuschner M, Wunderlich N, Nickel A, Bhatti S, Hubner K, Leuschener U: Cholic acid and ursodeoxycholic acid therapy in primary biliary cirrhosis. Changes in bile acid patterns and their correlation with liver function. Eur J Clin Pharmacol 45:221-225, 1993
39. 39. Marcus SN, Heaton KW: Intestinal Transit, deoxycholic acid and the cholesterol saturation of bile-three interrelated factors. Gut 27:550-558, 1986
40. 40. Barr F, Pratschke E, Fisher S, Paumgartner G: Disorders of bile acid metabolism in cholesterol gallstone disease. J Clin Invest 90:859-868, 1992
41. 41. Angelin B, Einarsson K, Leijd B: Biliary lipid composition during treatment with different hypolipidaemic drugs. Eur J Clin Invest 9:185-190, 1977
42. 42. Carrella M, Ericsson S, Del Piano C, Angelin B, Einarsson K: Effect of cholestyramine treatment on biliary lipid secretion rated in normolipidaemic men. J Int Med 229:241-246, 1991
43. 43. Ettinger WH Jr, Hazzard WR: Prednisone increases very low density lipoprotein and high density lipoprotein in healthy men. Metabolism 37:1055-1058, 1988
44. 44. Jefferys DB, Lessof MH, Mattock MB: Corticosteroid treatment, serum lipids and coronary artery disease. Postgrad Med 56:491-493, 1980